Entities / Company
Pluri Inc..
Israeli company engaged in the development of human placental adherent stromal cells for commercial use
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Pluri Inc. majority-owns Ever After Foods and utilizes its cell-based technology in partnership with EAF to establish a scientific presence in Belgium.Some support1 report
-
Pluri Inc. is listed on the Nasdaq exchange and focusing on US commercial activity, while Alejandro Weinstein holds over 30% ownership. Separately, Abbott acquired CFR Pharmaceuticals for $2.9 billion.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Pluri Inc. this week
News at the entities that move Pluri Inc. most-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Pluri Inc.
-
company StructuralBoard approved a quarterly cash dividend increase on August 1, 2026.Moves Pluri Inc.
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves Pluri Inc.
Connections
The 5 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Alejandro Weinstein Structural
Alejandro Weinstein holds over 30% ownership in Pluri Inc.
-
Nasdaq Structural
Pluri Inc. is formally listed on the Nasdaq stock exchange, establishing a structural dependency on the market.
-
company Structural
Pluri Inc. operates within the company sector, acting as both a technology provider and a majority owner of other companies.
-
MarketBeat Mentioned together
MarketBeat reports and tracks Pluri Inc.'s average stock rating.
-
Cacao Shared context
Pluri Inc. operates within the cultivated cacao industry space.